Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | INVA Innoviva, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $21.14 +0.4% | $15.06 -2.0% |
| StockIQ Score | 66B- Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 58C | 13F |
| Fundamental | 83A- | 35F |
| Growth | 73B | 50C- |
| Fair Value | 67B- | 38F |
| News | 62C+ | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 62C+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Innoviva (INVA) outperforms Ascentage Pharma (AAPG) across nearly all categories. Its investor score (65 vs. 37), fundamental score (83 vs. 35), and growth score (73 vs. 50) are significantly higher, indicating stronger investor confidence, financial health, and growth potential. Only valuation (67 vs. 38) and technical scores (56 vs. 18) slightly favor INVA, while AAPG’s weak overall rating (WEAK vs. MODERATE) highlights its weaker performance.